secwatch.observer — SEC 8-K summary
======================================

Issuer:     UGI CORP /PA/ (UGI)
CIK:        0000884614
Form:       8-K
Filed at:   2021-07-01T23:59:59+00:00
Accession:  0000884614-21-000042
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

UGI names Jean Felix Tematio Dontsop as VP, Chief Accounting Officer
--------------------------------------------------------------------

- Appointment effective July 19, 2021; Tematio Dontsop most recently VP Internal Audit at West Pharmaceuticals.
- Previously held roles over 15 years at PwC (Audit Director) and earlier at KPMG.
- Will participate in annual bonus, long-term incentive plan, SERP, and Severance Plan.
- Change-in-control agreement provides two times base salary plus bonus upon qualifying termination.
- Holds CPA and master's degrees in Finance and Accounting from French and Cameroonian universities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884614/000088461421000042/0000884614-21-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884614/000088461421000042/ugi-20210701.htm
  HTML page:      https://secwatch.observer/filing/0000884614-21-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer